The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000527.5(LDLR):c.44T>A (p.Leu15His)

CA10584731

250980 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 84851a61-30e9-42f5-b890-0816f6ff06fd
Approved on: 2022-08-28
Published on: 2022-08-28

HGVS expressions

NM_000527.5:c.44T>A
NM_000527.5(LDLR):c.44T>A (p.Leu15His)
NC_000019.10:g.11089592T>A
CM000681.2:g.11089592T>A
NC_000019.9:g.11200268T>A
CM000681.1:g.11200268T>A
NC_000019.8:g.11061268T>A
NG_009060.1:g.5212T>A
ENST00000558518.6:c.44T>A
ENST00000455727.6:c.44T>A
ENST00000535915.5:c.44T>A
ENST00000545707.5:c.44T>A
ENST00000557933.5:c.44T>A
ENST00000557958.1:n.130T>A
ENST00000558013.5:c.44T>A
ENST00000558518.5:c.44T>A
ENST00000560502.5:n.130T>A
NM_000527.4:c.44T>A
NM_001195798.1:c.44T>A
NM_001195799.1:c.44T>A
NM_001195800.1:c.44T>A
NM_001195803.1:c.44T>A
NM_001195798.2:c.44T>A
NM_001195799.2:c.44T>A
NM_001195800.2:c.44T>A
NM_001195803.2:c.44T>A
NR_163945.1:n.68A>T

Uncertain Significance

Met criteria codes 1
PM2
Not Met criteria codes 25
PVS1 BS2 BS4 BS3 BS1 BP5 BP7 BP2 BP3 BP4 BP1 PS2 PS4 PS3 PS1 PP1 PP4 PP3 PP2 BA1 PM6 PM3 PM1 PM4 PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.44T>A (p.Leu15His) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying evidence code PM2 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: PM2 - This variant is absent from gnomAD (gnomAD v2.1.1), so PM2 is met.
Met criteria codes
PM2
This variant is absent from gnomAD (gnomAD v2.1.1), so PM2 is met.
Not Met criteria codes
PVS1
variant is missense and not in initiation codon, so not met
BS2
not identified in normolipidemic individuals, so not met
BS4
no family data
BS3
there are no functional studies on this variant
BS1
This variant is absent from gnomAD (gnomAD v2.1.1), so BS1 is not met.
BP5
not applicable
BP7
variant is missense, so not met
BP2
not identified in cases with other variants
BP3
not applicable
BP4
REVEL = 0.749. It is not below 0.50, so BP4 is not met
BP1
Not applicable
PS2
no de novo occurrence
PS4
not identified in index cases fulfilling clinical FH criteria, so not met
PS3
there are no functional studies on this variant
PS1
no other missense variant leads to the same amino acid change, so not met
PP1
no family data
PP4
not identified in index cases fulfilling clinical FH criteria, so not met
PP3
REVEL = 0.749. It is not above 0.75, so splicing evaluation is required: A - not on limits B - does not create GT C - there is no GT nearby so PP3 is not met
PP2
Not applicable
BA1
This variant is absent from gnomAD (gnomAD v2.1.1), so BA1 is not met.
PM6
no de novo occurrence
PM3
not identified in cases with other variants
PM1
variant is missense and meets PM2, but it is not in exon 4 and does not alter Cys, so not met
PM4
variant is missense, so not met
PM5
there is 1 other missense variant in the same codon: NM_000527.5(LDLR):c.44T>C (p.Leu15Pro) - Likely pathogenic so PM5 is not met
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.